Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation.
Neurol India
;
1999 Sep; 47(3): 206-9
Article
Dans Anglais
| IMSEAR
| ID: sea-120389
ABSTRACT
Twenty seven patients with hemifacial spasm (HFS) and sixteen patients with blepharospasm (BS) having mean Jankovic disability rating scale score of 2.56+0.58 SD and 2.81+0.54 SD, respectively, were treated with botulinum toxin A (BTX-A) injections. The total number of injection sessions were ninety one with relief response in 98.91%. The mean improvement in function scale score was 3.78+0.64 SD and 3.29+1.07 SD respectively, in HFS and BS groups. The clinical benefit induced by botulinum toxin lasted for a mean of 4.46+3.11 SD (range 2 to 13) months in HFS group and 2.66+1.37 SD (range 1 to 6) months, in BS groups. Transient ptosis was seen in 4.39% of total ninety one injection sessions. These findings show that local botulinum toxin treatment provides effective, safe and long lasting relief of spasms.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Facteurs temps
/
Blépharospasme
/
Sujet âgé
/
Humains
/
Études de suivi
/
Toxines botuliniques de type A
/
Adulte
/
Spasme hémifacial
/
Adulte d'âge moyen
/
Agents neuromusculaires
Type d'étude:
Étude observationnelle
/
Étude pronostique
langue:
Anglais
Texte intégral:
Neurol India
Année:
1999
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS